AU2003294100A1 - Use of hyaluronic acid for respiratory disorders or the upper airways - Google Patents

Use of hyaluronic acid for respiratory disorders or the upper airways

Info

Publication number
AU2003294100A1
AU2003294100A1 AU2003294100A AU2003294100A AU2003294100A1 AU 2003294100 A1 AU2003294100 A1 AU 2003294100A1 AU 2003294100 A AU2003294100 A AU 2003294100A AU 2003294100 A AU2003294100 A AU 2003294100A AU 2003294100 A1 AU2003294100 A1 AU 2003294100A1
Authority
AU
Australia
Prior art keywords
hyaluronic acid
respiratory disorders
upper airways
airways
respiratory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003294100A
Other versions
AU2003294100A8 (en
Inventor
Anthony Bresin
Martine Briet
Regis De Baynast
Franck Launay
Edith Puchelle
Beatrice Raby
Jean-Marie Zahm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Agro Industrie Recherches et Developpements ARD
Original Assignee
Agro Industrie Recherches et Developpements ARD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agro Industrie Recherches et Developpements ARD filed Critical Agro Industrie Recherches et Developpements ARD
Publication of AU2003294100A1 publication Critical patent/AU2003294100A1/en
Publication of AU2003294100A8 publication Critical patent/AU2003294100A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/12—Mucolytics
AU2003294100A 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways Abandoned AU2003294100A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/14979 2002-11-28
FR0214979A FR2847818B1 (en) 2002-11-28 2002-11-28 PHARMACEUTICAL COMPOSITION BASED ON HYALURONIC ACID
PCT/FR2003/003507 WO2004050187A1 (en) 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways

Publications (2)

Publication Number Publication Date
AU2003294100A1 true AU2003294100A1 (en) 2004-06-23
AU2003294100A8 AU2003294100A8 (en) 2004-06-23

Family

ID=32309802

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003294100A Abandoned AU2003294100A1 (en) 2002-11-28 2003-11-27 Use of hyaluronic acid for respiratory disorders or the upper airways

Country Status (3)

Country Link
AU (1) AU2003294100A1 (en)
FR (1) FR2847818B1 (en)
WO (1) WO2004050187A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060183709A1 (en) * 2005-02-15 2006-08-17 Ahmad Alkayali Preparation of low molecular weight hyaluronic acid as a food supplement
ITMI20060742A1 (en) 2006-04-13 2007-10-14 Patrizia Pattini ANTIBACTERIAL COMPOSITIONS FOR TREATMENT OF INFECTION OF HIGH AND LOW AIRCRAFT
FR2919185B1 (en) * 2007-07-23 2010-09-10 Ard Sa USE OF HYALURONIC ACID FOR THE PREPARATION OF COMPOSITIONS INTENDED TO IMPROVE THE CONDITION OF MUCOUS MEMBRANES
IT1396468B1 (en) * 2008-11-11 2012-12-14 Farma Derma Srl TOPIC USE OF HYALURONIC ACID FOR FILMOGEN ACTION IN PREPARATIONS FOR TREATMENT AND PROPHYLAXIS OF PATHOLOGIES OF THE RESPIRATORY PATHWAYS.
EP2985027B1 (en) 2014-08-16 2021-03-31 Church & Dwight Co., Inc. Nasal composition comprising mixture of hyaluronic acids and saline solution
EP2985019B1 (en) 2014-08-16 2021-10-20 Church & Dwight Co., Inc. Nasal composition having anti-viral properties
EP3415154A1 (en) 2017-06-16 2018-12-19 Sofibel S.A.S. Nasal composition
WO2023079072A1 (en) 2021-11-05 2023-05-11 INSERM (Institut National de la Santé et de la Recherche Médicale) Use of low molecular weight hyaluronic acid for the treatment of lung mucosal inflammation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3310994B2 (en) * 1991-07-03 2002-08-05 電気化学工業株式会社 Allergy treatment
US5633003A (en) * 1994-03-31 1997-05-27 Cantor; Jerome O. Use of intratracheally administered hyaluronic acid to ameliorate emphysema
US20020086852A1 (en) * 1998-05-14 2002-07-04 Cantor Jerome O. Method for treating respiratory disorders associated with pulmonary elastic fiber injury
ATE285250T1 (en) * 1998-06-01 2005-01-15 Chiron Corp USE OF POLYMERS OF HYALURONIC ACID FOR MUCOSAL RELEASE OF VACCINES AND ADJUVANTS
AU2002315330A1 (en) * 2001-06-15 2003-01-02 Exhale Therapeutics, Inc. Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid

Also Published As

Publication number Publication date
FR2847818B1 (en) 2008-04-04
FR2847818A1 (en) 2004-06-04
WO2004050187A1 (en) 2004-06-17
AU2003294100A8 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
AU2003279338A1 (en) Phenethanolamine derivatives for the treatment of respiratory diseases
HUS1400011I1 (en) Novel medicaments for the treatment of chronic obstructive pulmonary diseases
HK1081173A1 (en) Phenethanolamine derivative for the treatment of respiratory diseases
AU2003285091A1 (en) Interferon antagonists useful for the treatment of interferon related diseases
IL179906A0 (en) Novel hydantoin derivatives for the treatment of obstructive airway diseases
AU2003233583A1 (en) Oral lactoferrin in the treatment of respiratory disorders
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
AU2003210428A1 (en) Phenethanolamine derivatives for treatment of respiratory diseases
AU2003286567A1 (en) Methods for the treatment of skin disorders
PT1656346E (en) 1,2,3,4-tetrasubstituted indole for the treatment of respiratory diseases
IL181049A0 (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
PT1530466E (en) Use of nintedanib for the treatment of lung fibrosis
AUPS017702A0 (en) Methods and compositions for the treatment of asthma and related disorders
AU2003294100A1 (en) Use of hyaluronic acid for respiratory disorders or the upper airways
PL371426A1 (en) Diclofenac-based composition for the topical treatment of oropharyngeal cavity disorders
AU2003289652A1 (en) The use of compound helicid for manufacturing medicine to treat depresion and/or disorders caused by depresion
AU2003205898A1 (en) Combination therapy for respiratory disorders
HRP20041160A2 (en) Novel combination for the treatment of airway disorders
AU2003269257A1 (en) Use of cap-1 for the therapy of asthma
AU2003273856A1 (en) Vr1 antagonists for the treatment of urological disorders
AU2002315330A1 (en) Treatment of respiratory conditions associated with bronchoconstriction with aerosolized hyaluronic acid
AU2003278420A1 (en) Process for the preparation of ganciclovir
HRP20041159A2 (en) Combination for the treatment of airway disorders
GB0201025D0 (en) The treatment of degenerative diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase
TH Corrigenda

Free format text: IN VOL 18, NO 29, PAGE(S) 7783 UNDER THE HEADING APPLICATIONS OPI - NAME INDEX UNDER THE NAME AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.), APPLICATION NO. 2003294100, UNDER INID (71) CORRECT THE NAME TO READ INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM); AGRO INDUSTRIE RECHERCHES ET DEVELOPPEMENTS (A.R.D.)